Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia: A placebo controlled multicenter study

International Angiology

Volumn 15, Issue 1, 1996, Pages 75-80

  Myhre, Hans O ^a   Peterson, Lars Erik ^b   Broyn T ^c   Hoivik B ^c   Mjaseth B ^c   Dedichen, H ^d   Hauss, G ^e   Kroese, A ^f   Krohg Sorensen K ^f   Kordt, K ^g   Normann, E ^h   Johnsen, G ^a   Dokke, J ⁱ   Lie, M ^j   Bugge Asperheim, B ^k   Artun K ^l  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Akershus Hospital

^d Ullevål Hospital

^e Skien Hospital

^f Aker Hospital

^g Stavanger Hospital

^h Tønsberg Hospital

ⁱ Moss Hospital

^j UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^k Arendal Hospital

^l Hedermark Hospital

more..

Author keywords

Critical lower limb ischemia; Pain measurement; Pentoxifylline; Placebo controlled investigation

Indexed keywords

ANTITHROMBOCYTIC AGENT; PENTOXIFYLLINE; PERIPHERAL VASODILATING AGENT;

ADULT; AGED; ARTERIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN; RANDOMIZED CONTROLLED TRIAL; SITTING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; VERTIGO;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIA; LEG; MALE; PAIN MEASUREMENT; PENTOXIFYLLINE; PROSPECTIVE STUDIES; TIME FACTORS; VASODILATOR AGENTS;

EID: 0029865212     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 1982;104:66-71.
2. Rossner M, Müller R. On the assessment of the efficacy of pentoxifylline. J Med 1987;18:1-15.
3. Lindgärde F, Jelnes R, Björkman H et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 1989;80:1549-56.
4. Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: A critical analysis of the methods and findings of published clinical trials, 1965-1985. Br J Clin Pharmacol 1988;26:569-76.
5. Angelides NS. Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease. Angiology 1986;27:555-64.
6. McCollum PT, Kent P, O'Driscoll K et al. Intravenous pentoxifylline in the treatment of rest pain: A preliminary report. Ann Vasc Surg 1981;1:220-3.
7. Galvin KT, Gorst KL, Primrose JN et al. Intravenous oxypentifylline in critical limb ischaemia. Br J Clin Pract 1989;43:169-72.
8. Van der Brand P, Munck D, Wautrechts J et al. Intravenous pentoxifylline for the treatment of chronic critical limb ischemia. The European Study Group. Eur J Vasc Endovasc Surg 1995;9:426-36.
9. Bell PRF, Charlesworth D, DePalma RG et al. The definition of critical ischaemia of a limb. Br J Surg 1982;69(suppl):S2.
10. European Working Group on Critical Limb Ischaemia. Second European Consensus Document on chronic critical limb ischaemia. Circulation 1991;84(Suppl 4):1-22.
11. Bollinger A, Breddin K, Hess H et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 1981; 31:339-46.
12. Rudofsky G, Haussler KF, Kunkel HP et al. Intravenous treatment of chronic peripheral occlusive arterial disease: A double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline. Angiology 1989;40:639-49.
13. Clemens MR, Ruess M. Effect of pentoxifylline on erythrocyte membrane and plasma lipids. Eur J Clin Pharmacol 1991;41:623-4.
14. Johnson WC, Sentissi JM, Baldwin D et al. Treatment of claudication with pentoxifylline: Are benefits related to improvement in viscosity? J Vasc Surg 1987;6: 211-6.
15. Verhaeghe R, Verstraete M. Pentoxifylline in arterial disease of the legs. Eur J Clin Pharmacol 1991;41:507-9.
16. Nash GB, Thomas PRS, Dormandy JA. Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg. Br Med J 1988;296:1699-701.
17. Ciuffetti G, Mercuri M, Ott C et al. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Eur J Clin Pharmacol 1991;41:511-5.
18. Thomson GJL, Thomson S, Todd AS et al. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial. Int Angiol 1990;9:266-70.
19. Mandell GL. ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 1988;138:1103-5.
20. Davies MG, McCollum PT, Kent P et al. Intravenous pentoxifylline increases tissue oxygenation in the treatment of established ischaemic rest pain. Br J Clin Pharmacol 1988;26:650-1.
21. Roeren T, LeVeen RF, Nugent L. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy. Angiology 1988;39:929-33.
22. Gillings D, Koch G, Reich T et al. Another look at the pentoxifylline efficacy data for intermittent claudication. J Clin Pharmacol 1987;27:601-9.
23. Effeney DJ, Stokes JA, Trenery HM. The trial and tribulation of pentoxifylline. Perspect Vasc Surg 1992;5:123-37.